Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00641797 · ClinicalTrials.gov registry record · NA
Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
A NA study of Benign Paroxysmal Positional Vertigo, sponsored by Lehigh Valley Hospital.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT00641797 is a NA study of Benign Paroxysmal Positional Vertigo that has completed, run by Lehigh Valley Hospital. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00641797, a NA study of Benign Paroxysmal Positional Vertigo, has completed, sponsored by Lehigh Valley Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Benign Paroxysmal Positional Vertigo (BPPV) is a common complaint of emergency department patients. The importance of early diagnosis and treatment can lead to a much improved quality of life for patients afflicted by this ailment. It is the purpose of this study to evaluate and examine two methods of treatment. Patients will be randomized to receive the more common conventional medication therapy versus the canalith repositioning technique. All patients enrolled into this study are emergency department patients who have been diagnosed with BPPV via a positive Dix-Hallpike Maneuver. The hypothesis of this study is that vestibular rehabilitation will allow for resolution of symptoms without the use of conventional medication therapy in the acute management of BPPV in the emergency department patient.
Conditions Studied
Interventions
- DRUG Ondansetron
- DRUG Diphenhydramine
- DRUG Lorazepam
- DRUG Meclizine
- OTHER Epley Maneuver
Study Locations (1)
Pennsylvania
- Lehigh Valley Hospital - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-11 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00641797
The ClinicalTrials.gov registry entry for NCT00641797 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lehigh Valley Hospital, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Benign Paroxysmal Positional Vertigo appearing as the primary indexed condition, and to 5 interventions - of which Ondansetron is the first listed.
NCT00641797 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00641797 about?
NCT00641797 is a clinical study titled "Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients". Benign Paroxysmal Positional Vertigo (BPPV) is a common complaint of emergency department patients. The importance of early diagnosis and treatment can lead to a much improved quality of life for patients afflicted by this ailment. It is the purpose of this study to evaluate and examine two methods ...
What is the current status of trial NCT00641797?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2006-11. Estimated completion is 2013-11.
What conditions does trial NCT00641797 study?
This clinical trial studies the following conditions: Benign Paroxysmal Positional Vertigo.
What interventions are being tested in trial NCT00641797?
The interventions under investigation include: Ondansetron (DRUG), Diphenhydramine (DRUG), Lorazepam (DRUG), Meclizine (DRUG), Epley Maneuver (OTHER).
Who is sponsoring clinical trial NCT00641797?
This trial is sponsored by Lehigh Valley Hospital, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00641797 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.